MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
0.9630
-0.0121 (-1.24%)
At close: May 15, 2026, 4:00 PM EDT
0.9303
-0.0327 (-3.40%)
After-hours: May 15, 2026, 6:20 PM EDT
MIRA Pharmaceuticals Market Cap
MIRA Pharmaceuticals has a market cap or net worth of $40.47 million as of May 15, 2026. Its market cap has increased by 113.26% in one year.
Market Cap
40.47M
Enterprise Value
31.06M
1-Year Change
113.26%
Ranking
Category
Stock Price
$0.96
Market Cap Chart
Since the IPO on August 3, 2023, MIRA Pharmaceuticals's market cap has decreased from $103.22M to $40.47M, a decrease of -60.79%. That is a compound annual growth rate of -28.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 40.39M | 57.47% |
| Dec 31, 2025 | 25.65M | 35.17% |
| Dec 31, 2024 | 18.98M | 22.26% |
| Dec 29, 2023 | 15.52M | -84.96% |
| Aug 3, 2023 | 103.22M | - |
View and export this data all the way back to 2023. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pfizer | 146.76B |
| Bristol-Myers Squibb Company | 115.93B |
| Sanofi | 102.61B |
| GSK plc | 100.77B |
| Biogen | 28.25B |
| Grifols | 6.57B |
| Organon & Co. | 3.51B |
| Amarin Corporation | 309.92M |